REG-Norges Bank: Form 8.3 - Horizon Therapeutics Plc

Horizon TherapeuticsAnnouncement

28/09/2023 09:45

 
FORM 8.3
 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE

1. KEY INFORMATION

 

 Name of person dealing (Note 1)                                                    Norges Bank                           
 Company dealt in                                                                   Horizon Therapeutics Plc              
 Class of relevant security to which the dealings being disclosed relate (Note 2)c  $0.0001 ordinary shares IE00BQPVQZ61  
 Date of dealing                                                                    27/09/2023                            

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)

                                              Long                    Short              
                                              Number          (%)     Number      (%)    
 (1) Relevant securities                      6,945,717 (3.03%)                          
 (2) Derivatives (other than options)                                                    
 (3) Options and agreements to purchase/sell                                             
 Total                                        6,945,717 (3.03%)                          

 

(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)

 Class of relevant security:                  Long             Short            
                                              Number      (%)  Number      (%)  
 (1) Relevant securities                                                        
 (2) Derivatives (other than options)                                           
 (3) Options and agreements to purchase/sell                                    
 Total                                                                          


Ap20

 

 

1. DEALINGS (Note 4)

 

(a) Purchases and sales

 

 Purchase/sale  Number of relevant securities  Price per unit (Note 5)       
 Purchase       5,406                          USD           115.7000        
                                                                             
                                                                             
                                                                             
                                                                             

 

(b) Derivatives transactions (other than options transactions)

 

 Product name, e.g. CFD  Nature of transaction (Note 6)  Number of relevant securities (Note 7)  Price per unit (Note 5)  
                                                                                                                          

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

 Product name, e.g. call option  Writing, selling, purchasing, varying etc.  Number of securities to which the option relates (Note 7)  Exercise price  Type, e.g. American, European etc.  Expiry date  Option money paid/received per unit (Note 5)  
                                                                                                                                                                                                                                                       

 

(ii) Exercising

 

 Product name, e.g. call option  Number of securities  Exercise price per unit (Note 5)  
                                                                                         

 

(d) Other dealings (including transactions in respect of new securities)
(Note 4)

 

 Nature of transaction (Note 8)  Details  Price per unit (if applicable) (Note 5)  
                                                                                   


Ap21

 
2. OTHER INFORMATION
 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note
9)                                          
 YES/NO

 

 Date of disclosure                                                28/09/2023         
 Contact name                                                      Philippe Chiaroni  
 Telephone number                                                  004724073297       
 If a connected EFM, name of offeree/offeror with which connected                     
 If a connected EFM, state nature of connection (Note 10)                             

 

 

 

 



Copyright (c) 2023 PR Newswire Association,LLC. All Rights Reserved